A Bioequivalence Study of Capecitabine Tablets

NCT01846650 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer or Metastatic Colorectal Cancer

Interventions

DRUG: Capecitabine tablets
DRUG: XELODA

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.